您当前的位置：
首页 >
文章列表页 >
GPR65 as a potential novel therapeutic target for the treatment of hepatic fibrosis
COMMENTARY | 更新时间：2025-12-13
上一篇|下一篇

    • GPR65 as a potential novel therapeutic target for the treatment of hepatic fibrosis

    • GPR65 as a potential novel therapeutic target for the treatment of hepatic fibrosis

    • “在xxx领域，xx专家取得了重大进展。他们建立了xx体系/探索了xx主题/验证了xx猜想，为解决xx问题提供了解决方案，为xx的未来研究铺平了道路。”
    • Leila Gobejishvili
    • MMR 2024年11卷第6期 页码：963-964

    • DOI： 10.1186/s40779-023-00507-2     

      中图分类号：

    移动端阅览

  •  
  •  

  • AI导读

  • HTML全文

  • 参考文献

  • 出版信息

  • 数据统计

27

浏览量

21

下载量

0

CSCD

文章被引用时，请邮件提醒。
提交
工具集
  • BibTeX下载
  • Endnote下载
  • RefMan 下载
  • NoteExpress下载
  • NoteFirst下载

相关文章

Metabolic syndrome and risk of sepsis and sepsis-related mortality: evidence from two large prospective cohort studies
The emerging role of ferroptosis in the pathological development and progression of sepsis
Hypoxia: a critical pathophysiological driver in respiratory inflammatory diseases
Healing of tendon-related diseases: insights from macrophage regulation
From RCT to mechanistic study: ATRA reverses myofibroblast activation by reprogramming glucose metabolism via HIC1 and PCK1/2 to attenuate hypertrophic scar formation

相关作者

Shao-Yu Liu
Shao-Kang Xu
Jing-Li Gao
Xiao-Ke Kong
Jian Shi
Ya Miao
Yi-Ting Tang
Bin Zhao

相关机构

Department of Cardiology, Kailuan General Hospital
Department of Critical Care Medicine and Hematology, the Second Xiangya Hospital, Central South University
Department of Critical Care Medicine and Hematology, the Third Xiangya Hospital, Central South University
Department of Intensive Medicine, Kailuan General Hospital
National Clinical Research Center for Endocrine and Metabolic Diseases, Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Metabolism and Endocrinology, the Second Xiangya Hospital of Central South University